Showing results (181-190 of 239) with videos related to

Sort By:
Pageof 24
Hepatology (Baltimore, Md.)|March 30, 2023
Predicting liver-related events in NAFLD: A predictive modelLuis Calzadilla-Bertot, Gary P Jeffrey, Zhengyi Wang, et al.
The Lancet. Gastroenterology & Hepatology|August 8, 2021
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statementMohammed Eslam, Naim Alkhouri, Pietro Vajro, et al.
International Journal of Telemedicine and Applications|March 22, 2022
Healthcare Providers' Perspective about the Use of Telemedicine in Egypt: A National SurveyMohamed Alboraie, Mohammad Abdalgaber, Naglaa Youssef, et al.
Hepatology (Baltimore, Md.)|August 24, 2019
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic AdaptationFei Chen, Saeed Esmaili, Geraint B Rogers, et al.
Journal of Hepatology|April 29, 2014
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infectionMohammed Eslam, Reynold Leung, Manuel Romero-Gomez, et al.
The Lancet. Gastroenterology & Hepatology|July 15, 2021
Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseasesMohammed Eslam, Aijaz Ahmed, Jean-Pierre Després, et al.
Journal of Multidisciplinary Healthcare|November 3, 2021
Predictors for Severity of SARS-CoV-2 Infection Among Healthcare WorkersFathiya El-Raey, Mohamed Alboraie, Naglaa Youssef, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2021
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver diseaseStefania Grimaudo, Paola Dongiovanni, Jussi Pihlajamäki, et al.
Journal of Hepatology|November 4, 2018
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTRMayada Metwally, Ali Bayoumi, Manuel Romero-Gomez, et al.
Pageof 24